William Michael Rosellini

William Michael Rosellini was the founder of Nuviant Medical, Inc. (2014), holding the title of Chief Executive Officer & Director.
Mr. Rosellini was the founder of MicroTransponder, Inc. (2006), holding the title of Chairman & Chief Executive Officer.
Mr. Rosellini was the founder of Rosellini Scientific LLC (2005), holding the title of Chairman.
Mr. Rosellini is the founder of Cytoimmune Therapeutics, Inc. (2019), holding the title of President & Head-Media Enquiries.
Mr. Rosellini is also the founder of Texas Onsite Dental.
Former positions include President, Chief Executive Officer & Director at Nexeon MedSystems, Inc. (2015-2020), Chief Executive Officer at Lexington Technology Group, Inc. (2012-2013), Chief Executive Officer at Perimeter Medical Imaging AI, Inc. (2019-2020), Chief Executive Officer at Sarif Biomedical LLC (2013-2014), Independent Director at MARA Holdings, Inc. (2013-2016), and Commercialization Director at The University of Texas at Dallas (2013-2015).
Education includes graduate degrees from the University of Southern California and Rutgers State University of New Jersey, graduate, MBA, and doctorate degrees from The University of Texas at Austin, an undergraduate degree from the University of Dallas, and a graduate degree from Maurice A. Deane School of Law at Hofstra University (2006).